TSE:4528Pharmaceuticals
Why Ono Pharmaceutical (TSE:4528) Is Up 7.9% After Stronger Nine-Month EPS And Profitability – And What's Next
Ono Pharmaceutical Co., Ltd. reported past nine‑month results to December 31, 2025, with sales of ¥397,036 million and net income of ¥68,949 million, both higher than the prior year period.
The increase in both basic and diluted earnings per share from continuing operations highlights improved profitability over the same nine‑month span a year earlier.
Next, we will examine how Ono Pharmaceutical’s higher earnings per share shapes the company’s investment narrative for investors and...